Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in 360 DigiTech, Inc., of Class Action Lawsuit and Upcoming Deadline - QFIN ..
Sep 27, 2021Pomerantz LLP announces that a class action lawsuit has been filed against 360 DigiTech, Inc. and certain of its officers. The class action, filed in the United States District Court for the Southern District of New York, an.....
Read MorePomerantz Law Firm Reminds Shareholders with Losses on their Investment in CorMedix Inc. of Class Action Lawsuit and Upcoming Deadline - CRMD .
Sep 27, 2021Pomerantz LLP announces that a class action lawsuit has been filed against CorMedix Inc. and certain of its officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed u.....
Read MoreWhite Paper Outlines Best Practices in Private Credit Responsible Investment Strategies
Sep 27, 2021Benefit Street Partners ("BSP"), a leading credit-focused alternative asset management firm and a wholly owned subsidiary of Franklin Resources, Inc. that, together with its various subsidiaries, operates as Franklin Templeton, al.....
Read MorePomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ardelyx, Inc. of Class Action Lawsuit and Upcoming Deadline - ARDX
Sep 27, 2021Pomerantz LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. and certain of its officers. The class action was filed in the United States District Court for the Northern District of California, Oakland.....
Read MoreJennifer Keller and Reuben Camper Cahn selected as "Top 100 Lawyers in California"
Sep 27, 2021Keller/Anderle LLP is pleased to announce that two of our partners, Jennifer Keller and Reuben Camper Cahn, have been selected to theLos Angeles and San Francisco Daily Journals' list of "The Top 100 Lawyers in Californi.....
Read MorePomerantz Law Firm Reminds Shareholders with Losses on their Investment in Iterum Therapeutics plc of Class Action Lawsuit and Upcoming Deadline - ITRMPomerantz LLP announces that a class action lawsuit has been filed against Iterum Therapeutics plc ("Iterum" or the "Company") (NASDAQ: ITRM) and certain of its officers. The class action, filed in the United States District Court for the Northern District of Illinois, Eastern Division, and docketed under 21-cv-04181, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Iterum securities between November 30, 2020 and July 23, 2021, both dates inclusive (the "Class Period"), seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials. If you are a shareholder who purchased or otherwise acquired Iterum securities during the Class Period, you have until October 4, 2021 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. [Click here for information about joining the class action] Iterum is a clinical-stage pharmaceutical company that engages in developing anti-infectives for multi-drug resistant pathogens in Ireland and the United States. The Company is developing sulopenem, a novel anti-infective compound with oral and intravenous formulations that is in Phase III clinical trials for the treatment of, among other medical issues, uncomplicated urinary tract infections ("uUTIs"). In November 2020, Iterum submitted a New Drug Application ("NDA") to the U.S. Food and Drug Administration ("FDA") for sulopenem etzadroxil/probenecid (oral sulopenem) for the treatment of uUTIs in patients with a quinolone non-susceptible pathogen (the "sulopenem NDA"). The complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) the sulopenem NDA lacked sufficient data to support approval for the treatment of adult women with uUTIs caused by designated susceptible microorganisms proven or strongly suspected to be non-susceptible to a quinolone; (ii) accordingly, it was unlikely that the FDA would approve the sulopenem NDA in its current form; (iii) Defendants downplayed the severity of issues and deficiencies associated with the sulopenem NDA; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times. On July 1, 2021, Iterum issued a press release "announc[ing] that the Company received a letter from the [FDA] stating that, as part of their ongoing review of the [sulopenem NDA], the agency has identified deficiencies that preclude the continuation of the discussion of labeling and post marketing requirements/commitments at this time." The press release further stated that "[n]o details with respect to deficiencies were disclosed by the FDA in this notification and the letter further states that the notification does not reflect a final decision on the information under review." On this news, Iterum's ordinary share price fell $0.87 per share, or 37.99%, to close at $1.42 per share on July 2, 2021. Then, on July 26, 2021, Iterum issued a press release announcing that it had received a Complete Response Letter from the FDA for the sulopenem NDA, "provid[ing] that the FDA has completed its review of the NDA and has determined that it cannot approve the NDA in its present form." Specifically, "the FDA determined that additional data are necessary to support approval for the treatment of adult women with [uUTIs] caused by designated susceptible microorganisms proven or strongly suspected to be non-susceptible to a quinolone[,]" while "recommend[ing] that Iterum conduct at least one additional adequate and well-controlled clinical trial, potentially using a different comparator drug[,]" and "conduct further nonclinical investigation to determine the optimal dosing regimen . . . ." On this news, Iterum's ordinary share price fell $0.499 per share, or 44.16%, to close at $0.631 per share on July 26, 2021. Pomerantz LLP, with offices in New York, Chicago, Los Angeles, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. CONTACT: Robert S. Willoughby Pomerantz LLP [email protected] 888-476-6529 ext. 7980
Sep 27, 2021Pomerantz LLP announces that a class action lawsuit has been filed against Iterum Therapeutics plc and certain of its officers. The class action, filed in the United States District Court for the Northern District of Illinoi.....
Read MoreHAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Announces Investigation into Berkeley Lights (BLI) and Possible Securities Law Violations, Encourages Investors with Significant Loss to Contact Firm's Attorneys Now
Sep 27, 2021Hagens Berman urges Berkeley Lights, Inc. investors with significant losses to submit your losses . Visit: www.hbsslaw.com/investor-fraud/BLIContact An Attorney Now: [email protected] 844-916-0895 Berkeley Lights, Inc.....
Read MorePomerantz Law Firm Reminds Shareholders with Losses on their Investment in Coinbase Global, Inc., of Class Action Lawsuit and Upcoming Deadline - COIN .
Sep 27, 2021Pomerantz LLP announces that a class action lawsuit has been filed against Coinbase Global, Inc. and certain of its officers. The class action, filed in the United States District Court for the Northern District of California, an.....
Read MoreUrbx Moves to Dismiss Meritless Attabotics Lawsuit
Sep 27, 2021Urbx, the on-demand robotics fulfillment system for last-mile delivery, has filed a Motion to Dismiss the meritless patent infringement lawsuit filed by Attabotics in the United States District Court for the District of Massachusetts. .....
Read MorePomerantz Law Firm Reminds Shareholders with Losses on their Investment in ATI Physical Therapy, Inc. f/k/a Fortress Value Acquisition Corp. II of Class Action Lawsuit and Upcoming Deadline - ATIP
Sep 27, 2021Pomerantz LLP announces that a class action lawsuit has been filed against ATI Physical Therapy, Inc. f/k/a Fortress Value Acquisition Corp. II ("FVAC") and certain of its officers. The class action, filed in the United States Di.....
Read MoreBW Global Group Petitions International Criminal Court To Investigate Alleged Nigerian Government Atrocities In Biafra
Sep 27, 2021BW Global Group, LLC, (BWGG) a human rights and government accountability advocacy firm in Washington, D.C., today, filed a formal communication with the Office of the Prosecutor ("OTP") of the International Criminal Court ("ICC"). This filing w.....
Read MoreHarborside Inc. Announces Strategic Agreement in Cannabis Crop Steering Research
Sep 27, 2021Harborside Inc. a California-focused, vertically integrated cannabis enterprise, today announced that it has entered into a strategic research agreement with Utah State University to conduct a study led by world-renowned plant physiolo.....
Read MorePomerantz Law Firm Reminds Shareholders with Losses on their Investment in Generac Holdings Inc. of Class Action Lawsuit and Upcoming Deadline - GNRC
Sep 27, 2021Pomerantz LLP announces that a class action lawsuit has been filed against Generac Holdings Inc. and certain of its officers. The class action, filed in the United States District Court for the Central District of California.....
Read MorePomerantz Law Firm Reminds Shareholders with Losses on their Investment in Oatly Group AB of Class Action Lawsuit and Upcoming Deadline - OTLY .
Sep 27, 2021Pomerantz LLP announces that a class action lawsuit has been filed against Oatly Group AB and certain of its officers. The class action, filed in the United States District Court for the Southern District of Ne.....
Read MoreLegal-Bay Lawsuit Funding Continues to Assist Sexual Abuse Victims Nationally Despite Challenges
Sep 27, 2021Legal-Bay, The Pre Settlement Funding Company, announced today that they are actively funding lawsuit loans for sexual abuse cases despite a backlogged court system. Covid shutdowns were responsible for putting many cases on hold indefinitely. But ev.....
Read MorePomerantz Law Firm Reminds Shareholders with Losses on their Investment in RenovaCare, Inc. of Class Action Lawsuit and Upcoming Deadline - RCAR .
Sep 27, 2021Pomerantz LLP announces that a class action lawsuit has been filed against RenovaCare, Inc. and certain of its officers. The class action, filed in the United States District Court for the District of New Jersey, and docketed und.....
Read MoreUrbx Moves to Dismiss Meritless Attabotics Lawsuit
Sep 27, 2021Urbx, the on-demand robotics fulfillment system for last-mile delivery, has filed a Motion to Dismiss the meritless patent infringement lawsuit filed by Attabotics in the United States District Court for the District of Massachusetts. .....
Read MorePJ SOLOMON Renames as Solomon Partners
Sep 27, 2021New Name Reflects Evolution to Diversified Firm Advising Clients in Over a Dozen Industries NEW YORK – Sept. 27, 2021 -- PJ SOLOMON, an independent affiliate of Natixis and part of Group BPCE, announced the change of its corporate name to Solomon.....
Read MoreTallahassee hospital tests new proprietary disinfectant platform
Sep 27, 2021CHARLESTON, S.C. - In June of 2020, Tallahassee Memorial Hospital got a first glance of the newly developed Paerosol MAG, or micro-aerosol generator, to help stop the spread of the COVID-19 virus. The Paerosol MAG, or micro-aerosol generator, uses pr.....
Read MoreVuuzle Studios Founder Humiliates S.E.C and AUSA Jenifer Weir by proving that their stories were bogus by installing 24-hour online video feeds Inside Film Studios and Backlot
Sep 26, 2021AUSA Jenifer Weir is known in California for filing fraudulent indictments on innocent people. She has been doing this for many years while making sure to conceal her identity from the world wide web. AUSA Jenifer Weir has been harboring a vendetta.....
Read MoreSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Sesen Bio, Inc. of Class Action Lawsuit and Upcoming Deadline - SESN
Sep 24, 2021Pomerantz LLP announces that a class action lawsuit has been filed against Sesen Bio, Inc. and certain of its officers. The class action, filed in the United States District Court for the Southern District of New York, and do.....
Read MoreSHAREHOLDER ALERT: WeissLaw LLP Investigates GreenSky, Inc.
Sep 24, 2021WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of GreenSky, Inc. in connection with the proposed acquisition of the Company by The Goldman Sachs Group, Inc.. .....
Read MoreSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Spectrum Pharmaceuticals, Inc of Class Action Lawsuit and Upcoming Deadline - SPPI
Sep 24, 2021Pomerantz LLP announces that a class action lawsuit has been filed against Spectrum Pharmaceuticals, Inc and certain of its officers. The class action, filed in the United States District Court for the District of Nevada, and dock.....
Read MoreTHE LAW FIRM OF TAMARA N. HOLDER, LLC: GFL Environmental, Inc. claims it does not have employees or do business in Tennessee, despite Waste Industries merger
Sep 24, 2021According to a federal lawsuit, Heather Cummins alleges she became an employee of publicly-traded GFL after it purchased Waste Industries, including her Clarksville, Tennessee location. Now, in GFL's attempt to be dismissed .....
Read MoreFlagship Pioneering Announces Appointment of Kathy Biberstein as General Counsel
Sep 24, 2021Flagship Pioneering, the bioplatform innovation company, announced today that Kathy Biberstein will join the company as General Counsel effective September 20, 2021. In this role, Biberstein will bring her significant expertise in lead.....
Read MorePomerantz Law Firm Reminds Shareholders with Losses on their Investment in Koninklijke Philips N.V. of Class Action Lawsuit and Upcoming Deadline - PHG
Sep 24, 2021Pomerantz LLP announces that a class action lawsuit has been filed against Koninklijke Philips N.V. and certain of its officers. The class action, filed in the United States District Court for the Eastern District of .....
Read More4LegalLeads.com Makes the Inc. 5000 by Helping Law Firms Grow During the Pandemic
Sep 24, 20214LegalLeads.com is celebrating its second year of inclusion on the Inc. 5000 list for 2021 by placing the spotlight on the attorneys who use its service to find new clients online. “After 20 years spent in online lead generation for the legal in.....
Read MoreFair Pay Workplace Certifies American Airlines, Anthem, Inc. and Four Others as Companies Achieving Pay Equity
Sep 24, 2021Fair Pay Workplace (FPW), the trusted symbol of pay equity around the world, today announced it has certified six companies, including American Airlines Group Inc. and Anthem, Inc. as Fair Pay Workplaces. Each company has undergone a .....
Read MorePomerantz Law Firm Reminds Shareholders with Losses on their Investment in AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp. of Class Action Lawsuit and Upcoming Deadline
Sep 24, 2021Pomerantz LLP announces that a class action lawsuit has been filed against AdaptHealth Corp. f/k/a DFB Healthcare Acquisitions Corp. and certain of its officers. The class action, filed in the United States District Court for the .....
Read MoreDeadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ATI Physical Therapy f/k/a Fortress Value Acquisition Corp. II (ATIP, FAVC)
Sep 24, 2021Law Offices of Howard G. Smith reminds investors of the upcoming October 15, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of investors who: (a) purchased ATI Physical Therapy, Inc. f/k/a Fortress .....
Read More